BioPharma Credit PLC is a private investment fund based in Exeter, United Kingdom. According to its most recent Form D, filed Apr 10, 2017, it has sold $270,598,450 of interests to 97 investors since its first sale in Mar 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Pablo Legoretta; Jeremy Sillem; Pedro Gonzalez de Cosio.
- Total raised
- $270,598,450Cumulative sales reported on Form D
- Investors
- 97
- First sale
- Mar 27, 2017
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Pablo Legoretta; Jeremy Sillem; Pedro Gonzalez de Cosio
- Latest Form D
- Apr 10, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about BioPharma Credit PLC
What is the minimum investment for BioPharma Credit PLC?
BioPharma Credit PLC's latest Form D, filed Apr 10, 2017, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in BioPharma Credit PLC?
BioPharma Credit PLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has BioPharma Credit PLC raised?
BioPharma Credit PLC reports $270,598,450 sold from 97 investors on its Form D filed Apr 10, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is BioPharma Credit PLC based?
BioPharma Credit PLC is based in Exeter, United Kingdom.
When did BioPharma Credit PLC launch?
BioPharma Credit PLC reports its first sale in Mar 2017.
Size compared with every private investment fund
Raised more than 77% of the 111 private investment funds based in United Kingdom, and more than 82% of all 10,333 that report sales.